Method of forming and the resulting membrane composition for surgical site preservation
View Patent ↗A method of forming and the resulting membrane composition for securement to a patient's bone or tissue to reduce the formation of tissue adhesions following a surgical procedure comprises a first component and a second component. The first component comprises a hydrogel including at least one crosslinked polymer. The second component comprises a textile component. The composition has a thickness between about two tenths of a millimeter (0.2 mm) to about six tenths of a millimeter (0.6 mm), a suture retention strength between about one Newton (1 N) to about thirteen Newtons (13 N), a static coefficient of friction between about one hundredth (0.01) and about one-half (0.5), a kinetic coefficient of friction between about one hundredth (0.01) and about one-half (0.5) and a flexibility of less than thirty millimeters (30 mm) bend length. A method of reducing the occurrence of tissue adhesions following surgery comprises applying the membrane composition to a surgical site.
1. A membrane composition for securement to a patient's bone or soft tissue to reduce the formation of tissue adhesions following a surgical procedure comprising a first component and a second component, the first component comprising a hydrogel including poly(vinyl alcohol) crosslinked to a second polymer, a ratio of the poly(vinyl alcohol) to the second polymer ranges from about 75:1 to about 200:1, the second component comprising a textile component, wherein the composition has a thickness between about two tenths of a millimeter (0.2 mm) to about six tenths of a millimeter (0.6 mm), a suture retention strength between about one Newton (1 N) to about thirteen Newtons (13 N), a static coefficient of friction between about one hundredth (0.01) and about one-half (0.5), a kinetic coefficient of friction between about one hundredth (0.01) and about one-half (0.5) and flexibility of less than thirty millimeters (30 mm) bend length, wherein the textile component is encapsulated by the first component, and the first component is configured to be in contact with the patient's bone or soft tissue when secured thereto.
2. The composition of claim 1 , wherein the second polymer is selected from the group consisting of poly(vinyl pyrrolidone), poly(hydroxyethylmethacrylate), poly(acrylamide), poly(acrylic acid), poly(acrylonitrile), polyethylene imine and poly(ethylene glycol).
3. The composition of claim 1 , wherein the second polymer is polyvinyl pyrrolidone.
4. The composition of claim 1 , wherein then ratio ranges from about 75:1 to about 110:1.
5. The composition of claim 1 , wherein the poly(vinyl alcohol) and the second polymer are crosslinked by a method selected from the group consisting of cryogelation, dehydration processing, radiation and exposure to chemicals.
6. The composition of claim 1 , wherein the textile component is selected from the group consisting of polypropylene, polyester, polyetheretherketone and expanded polytetrafluoroethylene.
7. The composition of claim 1 , wherein the textile component includes a plurality of pores situated between fibers of the textile component, wherein the pores are from about fifteen thousandths of a millimeter (0.015 mm) to about twelve and seven tenths millimeters (12.7) mm in size.
8. The composition of claim 1 , further comprising radiopaque markings.
9. A membrane composition for securement to a patient's bone or tissue comprising a first component and a second component, the first component comprising a hydrogel including poly(vinyl alcohol) and a second polymer selected from the group consisting of poly(vinyl pyrrolidone), poly(hydroxyethylmethacrylate), poly(acrylamide), poly(acrylic acid), poly(acrylonitrile), polyethylene imine and poly(ethylene glycol), wherein the poly(vinyl alcohol) and the second polymer are crosslinked and a ratio of the poly(vinyl alcohol) to the second polymer ranges from about 75:1 to about 200:1, the second component comprising a textile component, wherein the composition has sufficient thickness, suture retention strength, lubricity and flexibility to reduce the formation of tissue adhesions following a surgical procedure, wherein the textile component is encapsulated by the first component, and the first component is configured to be in contact with the patient's bone or soft tissue when secured thereto.
10. The composition of claim 9 , wherein the second polymer is polyvinyl pyrrolidone.
11. The composition of claim 9 , wherein the ratio ranges from about 75:1 to about 110:1.
12. The composition of claim 9 , wherein the poly(vinyl alcohol) and second polymer are crosslinked by a method selected from the group consisting of cryogelation, dehydration processing, radiation and exposure to chemicals.
13. The composition of claim 9 , wherein the textile component is selected from the group consisting of polypropylene, polyester, polyetheretherketone and expanded polytetrafluoroethylene.
14. The composition of claim 9 , wherein the textile component includes a plurality of pores situated between fibers of the textile component, wherein the pores are from about fifteen thousandths of a millimeter (0.015 mm) to about twelve and seven tenths millimeters (12.7 mm) in size.
15. The composition of claim 9 , further comprising radiopaque markings.
16. The composition of claim 9 , wherein the water content of the composition is between about fifty percent (50%) and about eighty percent (80%).
17. The composition of claim 9 , wherein the thickness of the composition is between about 0.2 mm to about 0.6 mm.
18. The composition of claim 9 , wherein the suture retention strength of the composition is between about one Newton (1 N) to about thirteen Newtons (13 N).
19. A membrane for use as a surgical implant comprising: a first component comprising a hydrogel including poly(vinyl alcohol) and a second polymer selected from the group consisting of polyvinyl pyrrolidone, poly(methyl methacrylate), poly(acrylamide), poly(acrylic acid), poly(acrylonitrile), polyethylene imine and poly(ethylene glycol), a ratio of the poly(vinyl alcohol) to the second polymer ranges from about 75:1 to about 200:1; and a second component comprising a textile component selected from the group consisting of polypropylene, polyester, polyetheretherketone and expanded polytetrafluoroethylene, wherein the textile component is formed of fibers having a thickness from about two hundredths of a millimeter (0.02 mm) to about three millimeters (3.00 mm), the fibers forming pores from about fifteen thousandths of a millimeter (0.015) mm to about twelve and seven tenths millimeters (12.7) mm in size and wherein the textile component is encapsulated by the first component, the membrane has a thickness between about two tenths of a millimeter (0.2 mm) and about six tenths of a millimeter (0.6 mm), wherein the textile component is encapsulated by the first component, and the first component is configured to be in contact with surrounding tissue when implanted.
20. The composition of claim 1 , wherein the textile component is encapsulated by only a single layer of the first component.